St. Johnʼs wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?

被引:0
作者
Gita Kholghi
Shirin Arjmandi-Rad
Mohammad-Reza Zarrindast
Salar Vaseghi
机构
[1] Islamic Azad University,Department of Psychology, Faculty of Human Sciences, Tonekabon Branch
[2] Shahid Beheshti University,Institute for Cognitive and Brain Sciences
[3] Tehran University of Medical Sciences,Department of Pharmacology, School of Medicine
[4] ACECR,Medicinal Plants Research Center, Institute of Medicinal Plants
来源
Naunyn-Schmiedeberg's Archives of Pharmacology | 2022年 / 395卷
关键词
St. Johnʼs wort; Hypericum perforatum; Depression; Neurotransmitters;
D O I
暂无
中图分类号
学科分类号
摘要
St. Johnʼs wort (Hypericum perforatum) is a herbaceous plant containing many bioactive molecules including naphthodianthrones, phloroglucinol derivatives, flavonoids, bioflavonoids, proanthocyanidins, and chlorogenic acid. Evidence has shown the therapeutic effects of St. Johnʼs wort and especially its two major active components, hyperforin and hypericin, on different psychiatric and mood disorders such as posttraumatic stress disorder (PTSD), attention-deficit hyperactivity disorder (ADHD), obsessive–compulsive disorder (OCD), and anxiety disorders. St. Johnʼs wort also induces antidepressant effects. In this review study, we aimed to discuss the role of St. Johnʼs wort in modulating depression, with respect to the role of different neurotransmitter systems in the brain. We discussed changes in the neurotransmitter levels in depression, and following use of St. Johnʼs wort. It was concluded that changes in the function and level of neurotransmitters in depression are complex. Also, St. Johnʼs wort can induce inconsistent effects on neurotransmitter levels. We also found that glutamate and acetylcholine may be the most important neurotransmitters to study in future works, because the function of both neurotransmitters in depression is unclear. In addition, St. Johnʼs wort induces a dualistic modulation on the activity of cholinergic signaling, which can be an interesting topic for future studies.
引用
收藏
页码:629 / 642
页数:13
相关论文
共 714 条
  • [1] aan het Rot M, Collins KA, Murrough JW, Perez AM, Reich DL, Charney DS, Mathew SJ, CG(2010)Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression Biol Psychiatry 67 139-145
  • [2] Abdallah G(2018)The neurobiology of depression, ketamine and rapid-acting antidepressants: is it glutamate inhibition or activation? Pharmacol Ther 190 148-158
  • [3] Sanacora RS(2021)Therapeutic potential of curcumin in reversing the depression and associated pseudodementia via modulating stress hormone, hippocampal neurotransmitters, and BDNF levels in rats Neurochem Res 46 3273-3285
  • [4] Duman JH(2019)(R)-Ketamine induces a greater increase in prefrontal 5-HT release than (S)-ketamine and ketamine metabolites via an AMPA receptor-independent mechanism Int J Neuropsychopharmacol 22 665-674
  • [5] Krystal A(2017)Adult hippocampal neurogenesis and cognitive flexibility—linking memory and mood Nat Rev Neurosci 18 335-346
  • [6] Afzal Z(2007)Interaction between a commercially available St. John's wort product (Movina) and atorvastatin in patients with hypercholesterolemia Eur J Clin Pharmacol 63 913-916
  • [7] Batool S(2011)NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses Nature 475 91-95
  • [8] Sadir L(2002)Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression Adv Ther 19 43-52
  • [9] Liaquat S(2017)Dopamine system dysregulation in major depressive disorders Int J Neuropsychopharmacol 20 1036-1046
  • [10] Shahzad S(2013)Serotonin and beyond: therapeutics for major depression Philos Trans R Soc Lond B Biol Sci 368 20120536-389